The share of corresponding/leading authors in scientific publications in drug discovery in France showed a small decline, with a starting value in 2023 moving slightly downward over the forecasted period from 2024 to 2028. The percentage has been declining consistently by an average of 0.12% year-on-year, suggesting a gradual shift towards a more distributed authorship structure in the coming years.
The compound annual growth rate (CAGR) for this period reflects a modest decrease, indicating a slow but steady trend away from the concentration of roles among corresponding/leading authors.
Future trends to watch include the potential for collaborative research models to become more prevalent, possibly influenced by global collaboration initiatives and multidisciplinary research efforts. An increase in co-authored publications might indicate a shift in how authorship roles are valued and assigned in the scientific community.
